Setterwalls advised EQL Pharma on the deal. EQL Pharma AB finalized the listing of the company’s shares on Nasdaq Stockholm. The trading on Nasdaq Stockholm commenced...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Swin Technologies AB (TrusTrace) on the deal. Swin Technologies AB (TrusTrace) raised USD 24 million in an investment round. The investment round was led by...
You must be a Standard 1 Year member to access this content.
Setterwalls advised Catena AB on the deal. Catena Logistik AB, a subsidiary of Catena AB, enters into an agreement to acquire Bockasjö AB. The acquisition takes...
You must be a Standard 1 Year member to access this content.
Setterwalls has assisted the owners of HPI Health Profile Institute AB on the deal. The owners of HPI Health Profile Institute AB announced the divestment of all...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised SynAct Pharma AB. SynAct Pharma AB announced the listing of the company’s shares on Nasdaq Stockholm, Mid Cap. The trading on Nasdaq Stockholm commenced...
You must be a Standard 1 Year member to access this content.
Sidley and Setterwalls advised inriver on the deal. Hannes Snellman advised Thomas H. Lee Partners. Inriver, a company that empowers organizations to deliver revenue-driving product information...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Resurs and Solid Försäkring on the deal. Resurs Holding AB announced the distribution of all shares in the wholly-owned subsidiary Solid Försäkringsaktiebolag (”Solid...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised ABG Sundal Collier on the deal, while Setterwalls has advised Resurs and Solid Försäkring. Solid Försäkring’s shares started trading on Nasdaq Stockholm. The...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Amniotics AB on the deal. Amniotics AB announced its listing on Nasdaq First North Growth Market. Amniotics is a biopharma company developing cell...
You must be a Standard 1 Year member to access this content.
Setterwalls represented Abboxia in the dispute. In April 2019 the Medical Products Agency decided to reject Abboxias’ application for marketing authorisation for parallel import of pharmaceuticals...
You must be a Standard 1 Year member to access this content.
